Scientific notes

Organ-on-a-Chip: A New Paradigm for Drug Development

Introduction

Organ-on-a-Chip is a potential, multidisciplinary method for in-vitro modeling of disease, drug screening, and precision medicine that simulates in-vitro physiology and pathology.
Organ-on-a-chip technology may be integrated organically into the drug development pipeline for preclinical screening, testing, and translating novel medicines from early drug discovery to bridging the gap between animal and human subject research.

In the future, it will be unprecedented to promote its biomedical applications through further development of customized organ-on-a-chip and ongoing integration of novel engineering tools (i.e. automation handling, 3D printing, in situ multi-Sensor systems) and biological concepts (e.g. patient-induced pluripotent stem cells and organoids).

How to culture vascularized & immunocompetent 3D models in a standard Multiwell

Abstract

The authors state that “The pharmaceutical industry has been desperately searching for efficient drug discovery methods. Organ-on-a-Chip, a cutting-edge technology that can emulate the physiological environment and functionality of human organs on a chip for disease modeling and drug testing, shows great potential for revolutionizing the drug development pipeline.

However, successful translation of this novel engineering platform into routine pharmacological and medical scenarios remains to be realized. In this review, we discuss how the Organ-on-a-Chip technology can have critical roles in different preclinical stages of drug development and highlight the current challenges in translation and commercialization of this technology for the pharmacological and medical end-users.

Moreover, this review sheds light on the future developmental trends and need for a next-generation Organ-on-a-Chip platform to bridge the gap between animal studies and clinical trials for the pharmaceutical industry.”.

References

Ma C, Peng Y, Li H, Chen W. Organ-on-a-Chip: A New Paradigm for Drug Development. Trends Pharmacol Sci. 2021 Feb;42(2):119-133. doi: 10.1016/j.tips.2020.11.009. Epub 2020 Dec 16. PMID: 33341248; PMCID: PMC7990030.

Related Posts

Illustration of a scientist conducting breast cancer research in a lab with test tubes, alongside a symbolic figure of a woman with a pink ribbon representing breast cancer awareness.
What’s new in breast cancer research? – July-August 2025...
Breast cancer is the second cancer-related cause of death in women worldwide, therefore it is no surprise breast cancer sits second in top d...
Read more
Comparison chart showing brown adipocyte and white adipocyte characteristics, including structure, function, fuel use, pathological concerns, and drug targets.
Brown vs White Adipose Tissue: What is at Stake for Pha...
As the global obesity crisis intensifies, the functional aspect of  brown adipose vs white adipose tissue has become a pivotal focus for me...
Read more
Review on the Vascularization of Organoids and Organoids-on-a-Chi...
Introduction Organoids and organs-on-a-chip (vascularized 3d culture) have seen rapid growth in recent years due to their importance in mi...
Read more

get in touch

Get the best insights about Cherry Biotech by Email Let’s stay in touch!
As part of our commercial prospecting, we may need to process your personal data. For more information, please consult our Privacy Policy